Skip to main content

We feel proud to share that our leaders, Pravin Anand and Safir Anand, have been featured in the fourth annual edition of the A-List released by the India Business Law Journal.

Pravin Anand has been ranked among India’s top 35 legal icons for having set several IP precedents in courts in matters related to Litigation and Dispute Resolution, and being a distinguished achiever in a career spanning over several decades.

Safir Anand has secured one of the most coveted positions among India’s top 100 most outstanding lawyers for his astute advisory on strategy, business models, marketing and commercial insight and his innovative approach and extraordinary contribution in Trademarks, Contractual and Commercial IP.

The A-List is an exclusive record that identifies the lawyers who in the eyes of the market have had exemplary performance and received several accolades from clients and international peers for not only their skills in particular areas of law, but also their attention to detail, trustworthiness and entrepreneurial approach to working with clients.

Most Recent

News & Insights

VIEW ALL
News & Updates, Thought Leadership
•
Nov 11, 2026

Think about the apps you use every day. Their visual identity is often the first thing you recognise: the arrangement of icons, navigation menus, buttons,

Can You Patent the Look of an App? GUI and Icon Protection in India
News & Updates, Thought Leadership
•
Nov 09, 2026

‘First published on Chambers’ By: Dhruv Anand, Dhananjay Khanna and Bhavya Verma It will not be an exaggeration to say that there has been an explosion

PERSONALITY RIGHTS – CURRENT TRENDS
News & Updates, Thought Leadership
•
Nov 09, 2026

‘First published on India Business Law Journal’ By: Shantanu Sahay and Pratyush Acharya As India moved towards full implementation of the Digital Personal

Treatment of legacy personal data under the DPDPA
News & Updates, Thought Leadership
•
Nov 07, 2026

Pharmaceutical innovation and access to medicines are closely connected aspects of public health. While patent protection can encourage investment in research

Can Public Health Override a Pharmaceutical Patent? The BPaL Patent Dispute in India